| Patent Number | Title | Applicant | Opposition Date |
|---|---|---|---|
| EP3324937 | Ready-To-Use Bortezomib Solution | STADA ARZNEIMITTEL AG | Aug 18, 2022 |
| EP3222272 | Pharmaceutical Composition | FERRING BV | Aug 1, 2022 |
| EP2234617 | Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters | JANSSEN PHARMACEUTICA NV | Dec 22, 2021 |
| EP2493466 | Novel Antitumoral Use Of Cabazitaxel | AVENTIS PHARMA S.A. | Mar 12, 2021 |
Feel free to send us a message here and we will get back to you